+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ophthalmic Pharmaceutical Drugs - Market Analysis, Trends, and Forecasts

  • ID: 344097
  • Report
  • 250 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Bayer Ag
  • F. Hoffmann-La Roche Ag
  • Kyowa Kirin Co., Ltd
  • Novartis International Ag
  • Pfizer, Inc
  • MORE
The Ophthalmic Pharmaceutical Drugs market worldwide is projected to grow by US$9.2 Billion, driven by a compounded growth of 4.5%. Anti-Inflammatory Drugs, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$9 Billion by the year 2025, Anti-Inflammatory Drugs will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.5% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$323.1 Million to the region's size and clout in the next 5 to 6 years. Over US$267.8 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Anti-Inflammatory Drugs will reach a market size of US$450.7 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.1% over the next couple of years and add approximately US$2.6 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Allergan PLC
  • Bayer AG
  • F. Hoffmann-La Roche AG
  • Johnson and Johnson Vision Care Inc
  • Kyowa Kirin Co., Ltd
  • Novartis International AG
  • Pfizer, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceuticals Co., Ltd.
  • Shire PLC
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Bayer Ag
  • F. Hoffmann-La Roche Ag
  • Kyowa Kirin Co., Ltd
  • Novartis International Ag
  • Pfizer, Inc
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Ophthalmic Pharmaceutical Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Ophthalmic Pharmaceutical Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Ophthalmic Pharmaceutical Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Ophthalmic Pharmaceutical Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Anti-Inflammatory Drugs (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Anti-Inflammatory Drugs (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Anti-Inflammatory Drugs (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Anti-Infective Drugs (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Anti-Infective Drugs (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Anti-Infective Drugs (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Anti-Glaucoma Drugs (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Anti-Glaucoma Drugs (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Anti-Glaucoma Drugs (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Anti-Allergic Drugs (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Anti-Allergic Drugs (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Anti-Allergic Drugs (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Other Drug Classes (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Other Drug Classes (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Other Drug Classes (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Prescription Drugs (Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025

TABLE 20: Prescription Drugs (Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 21: Prescription Drugs (Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Over-the-Counter Drugs (Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025

TABLE 23: Over-the-Counter Drugs (Type) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017

TABLE 24: Over-the-Counter Drugs (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Ophthalmic Pharmaceutical Drugs Market Share (in %) by Company: 2019 & 2025

TABLE 25: United States Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 26: Ophthalmic Pharmaceutical Drugs Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 27: United States Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 28: United States Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 29: Ophthalmic Pharmaceutical Drugs Market in the United States by Type: A Historic Review in US$ Million for 2009-2017

TABLE 30: United States Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

CANADA

TABLE 31: Canadian Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 32: Canadian Ophthalmic Pharmaceutical Drugs Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 33: Ophthalmic Pharmaceutical Drugs Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 34: Canadian Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 35: Canadian Ophthalmic Pharmaceutical Drugs Historic Market Review by Type in US$ Million: 2009-2017

TABLE 36: Ophthalmic Pharmaceutical Drugs Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

JAPAN

TABLE 37: Japanese Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 38: Ophthalmic Pharmaceutical Drugs Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 39: Japanese Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 40: Japanese Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 41: Ophthalmic Pharmaceutical Drugs Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 42: Japanese Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

CHINA

TABLE 43: Chinese Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 44: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017

TABLE 45: Chinese Ophthalmic Pharmaceutical Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 46: Chinese Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 47: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in China in US$ Million by Type: 2009-2017

TABLE 48: Chinese Ophthalmic Pharmaceutical Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Ophthalmic Pharmaceutical Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 49: European Ophthalmic Pharmaceutical Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 50: Ophthalmic Pharmaceutical Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 51: European Ophthalmic Pharmaceutical Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 52: European Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 53: Ophthalmic Pharmaceutical Drugs Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 54: European Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 55: European Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 56: Ophthalmic Pharmaceutical Drugs Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 57: European Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

FRANCE

TABLE 58: Ophthalmic Pharmaceutical Drugs Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 59: French Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 60: French Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 61: Ophthalmic Pharmaceutical Drugs Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 62: French Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 63: French Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

GERMANY

TABLE 64: Ophthalmic Pharmaceutical Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 65: German Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 66: German Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 67: Ophthalmic Pharmaceutical Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 68: German Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 69: German Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

ITALY

TABLE 70: Italian Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 71: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017

TABLE 72: Italian Ophthalmic Pharmaceutical Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 73: Italian Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 74: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Italy in US$ Million by Type: 2009-2017

TABLE 75: Italian Ophthalmic Pharmaceutical Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 76: United Kingdom Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 77: Ophthalmic Pharmaceutical Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 78: United Kingdom Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 79: United Kingdom Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 80: Ophthalmic Pharmaceutical Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 81: United Kingdom Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

SPAIN

TABLE 82: Spanish Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 83: Spanish Ophthalmic Pharmaceutical Drugs Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 84: Ophthalmic Pharmaceutical Drugs Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 85: Spanish Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 86: Spanish Ophthalmic Pharmaceutical Drugs Historic Market Review by Type in US$ Million: 2009-2017

TABLE 87: Ophthalmic Pharmaceutical Drugs Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

RUSSIA

TABLE 88: Russian Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 89: Ophthalmic Pharmaceutical Drugs Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 90: Russian Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 91: Russian Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 92: Ophthalmic Pharmaceutical Drugs Market in Russia by Type: A Historic Review in US$ Million for 2009-2017

TABLE 93: Russian Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 94: Rest of Europe Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 95: Ophthalmic Pharmaceutical Drugs Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 96: Rest of Europe Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 97: Rest of Europe Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 98: Ophthalmic Pharmaceutical Drugs Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 99: Rest of Europe Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 100: Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 101: Ophthalmic Pharmaceutical Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 102: Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 103: Ophthalmic Pharmaceutical Drugs Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 104: Asia-Pacific Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 105: Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 106: Ophthalmic Pharmaceutical Drugs Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 107: Asia-Pacific Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 108: Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 109: Ophthalmic Pharmaceutical Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 110: Australian Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 111: Australian Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 112: Ophthalmic Pharmaceutical Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 113: Australian Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 114: Australian Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

INDIA

TABLE 115: Indian Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 116: Indian Ophthalmic Pharmaceutical Drugs Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 117: Ophthalmic Pharmaceutical Drugs Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 118: Indian Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 119: Indian Ophthalmic Pharmaceutical Drugs Historic Market Review by Type in US$ Million: 2009-2017

TABLE 120: Ophthalmic Pharmaceutical Drugs Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

SOUTH KOREA

TABLE 121: Ophthalmic Pharmaceutical Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 122: South Korean Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 123: Ophthalmic Pharmaceutical Drugs Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025

TABLE 124: Ophthalmic Pharmaceutical Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 125: South Korean Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 126: Ophthalmic Pharmaceutical Drugs Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 127: Rest of Asia-Pacific Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 128: Ophthalmic Pharmaceutical Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 129: Rest of Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 130: Rest of Asia-Pacific Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 131: Ophthalmic Pharmaceutical Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 132: Rest of Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 133: Latin American Ophthalmic Pharmaceutical Drugs Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 134: Ophthalmic Pharmaceutical Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 135: Latin American Ophthalmic Pharmaceutical Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 136: Latin American Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 137: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017

TABLE 138: Latin American Ophthalmic Pharmaceutical Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 139: Latin American Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 140: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017

TABLE 141: Latin American Ophthalmic Pharmaceutical Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 142: Argentinean Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 143: Ophthalmic Pharmaceutical Drugs Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 144: Argentinean Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 145: Argentinean Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 146: Ophthalmic Pharmaceutical Drugs Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 147: Argentinean Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

BRAZIL

TABLE 148: Ophthalmic Pharmaceutical Drugs Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 149: Brazilian Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 150: Brazilian Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 151: Ophthalmic Pharmaceutical Drugs Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 152: Brazilian Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 153: Brazilian Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

MEXICO

TABLE 154: Ophthalmic Pharmaceutical Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 155: Mexican Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 156: Mexican Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 157: Ophthalmic Pharmaceutical Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 158: Mexican Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 159: Mexican Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 160: Rest of Latin America Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 161: Ophthalmic Pharmaceutical Drugs Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 162: Rest of Latin America Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 163: Rest of Latin America Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 164: Ophthalmic Pharmaceutical Drugs Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017

TABLE 165: Rest of Latin America Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 166: The Middle East Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 167: Ophthalmic Pharmaceutical Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 168: The Middle East Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 169: The Middle East Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 170: The Middle East Ophthalmic Pharmaceutical Drugs Historic Market by Drug Class in US$ Million: 2009-2017

TABLE 171: Ophthalmic Pharmaceutical Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 172: The Middle East Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 173: The Middle East Ophthalmic Pharmaceutical Drugs Historic Market by Type in US$ Million: 2009-2017

TABLE 174: Ophthalmic Pharmaceutical Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

IRAN

TABLE 175: Iranian Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 176: Ophthalmic Pharmaceutical Drugs Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 177: Iranian Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 178: Iranian Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 179: Ophthalmic Pharmaceutical Drugs Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 180: Iranian Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

ISRAEL

TABLE 181: Israeli Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 182: Ophthalmic Pharmaceutical Drugs Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 183: Israeli Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 184: Israeli Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 185: Ophthalmic Pharmaceutical Drugs Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 186: Israeli Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 187: Saudi Arabian Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 188: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017

TABLE 189: Saudi Arabian Ophthalmic Pharmaceutical Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 190: Saudi Arabian Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 191: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017

TABLE 192: Saudi Arabian Ophthalmic Pharmaceutical Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 193: Ophthalmic Pharmaceutical Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 194: United Arab Emirates Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 195: Ophthalmic Pharmaceutical Drugs Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025

TABLE 196: Ophthalmic Pharmaceutical Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 197: United Arab Emirates Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 198: Ophthalmic Pharmaceutical Drugs Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 199: Ophthalmic Pharmaceutical Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 200: Rest of Middle East Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 201: Rest of Middle East Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 202: Ophthalmic Pharmaceutical Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 203: Rest of Middle East Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 204: Rest of Middle East Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

AFRICA

TABLE 205: African Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 206: Ophthalmic Pharmaceutical Drugs Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 207: African Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 208: African Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 209: Ophthalmic Pharmaceutical Drugs Market in Africa by Type: A Historic Review in US$ Million for 2009-2017

TABLE 210: African Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

IV. COMPETITION

ALLERGAN PLC

BAYER AG

F. HOFFMANN-LA ROCHE AG

JOHNSON AND JOHNSON VISION CARE INC

KYOWA KIRIN CO., LTD

NOVARTIS INTERNATIONAL AG

PFIZER, INC

REGENERON PHARMACEUTICALS, INC.

SANTEN PHARMACEUTICALS CO., LTD.

SHIRE PLC

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Plc
  • Bayer Ag
  • F. Hoffmann-La Roche Ag
  • Johnson and Johnson Vision Care Inc
  • Kyowa Kirin Co., Ltd
  • Novartis International Ag
  • Pfizer, Inc
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceuticals Co., Ltd.
  • Shire Plc
Note: Product cover images may vary from those shown
Adroll
adroll